Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANITA phase II trial of nintedanib versus ifosfamide in advanced soft tissue sarcoma
NL-OMON50681Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nintedanib and ifosfamide in soft tissue sarcoma (STS), sponsored by European Organisation for Research and Treatment of Cancer. Started Feb 2018; status: completed.
02
Drugs
nintedanibifosfamide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NL-OMON50681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50681.